4.7 Article

The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Chemistry, Physical

Site-Specific Fragment Identification Guided by Single-Step Free Energy Perturbation Calculations

E. Prabhu Raman et al.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)

Article Chemistry, Multidisciplinary

Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations

Wenbo Yu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2012)

Article Oncology

Navitoclax (ABT-263) Reduces Bcl-xL-Mediated Chemoresistance in Ovarian Cancer Models

Maureen Wong et al.

MOLECULAR CANCER THERAPEUTICS (2012)

Review Pharmacology & Pharmacy

Emerging Bcl-2 inhibitors for the treatment of cancer

Asfar S. Azmi et al.

EXPERT OPINION ON EMERGING DRUGS (2011)

Review Chemistry, Multidisciplinary

CHARMM: The Biomolecular Simulation Program

B. R. Brooks et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Article Biochemical Research Methods

Computational Fragment-Based Binding Site Identification by Ligand Competitive Saturation

Olgun Guvench et al.

PLOS COMPUTATIONAL BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1

Catherine L. Day et al.

JOURNAL OF MOLECULAR BIOLOGY (2008)

Review Chemistry, Multidisciplinary

Scalable molecular dynamics with NAMD

JC Phillips et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Article Multidisciplinary Sciences

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

T Oltersdorf et al.

NATURE (2005)